Quantcast Pharmaceutical Industry News - Congoo
 
 
Log In
  HEALTHCARE >> PHARMACEUTICAL INDUSTRY    Get our Pharmaceutical Industry daily Briefing     
Biological sciences
Biotech
Cancer
Genetics
Health
Healthcare
Human sciences
Pharmaceutical Industry
Public health
 
 



Merck Presents Phase IIb Study Results at AHA Annual Scientific S...   - 11 Hours ago
Company: Merck & Co., Inc. (MRK) In a phase IIb study in 589 patients with primary hypercholesterolemia or mixed hyperlipidemia treated with anacetrapib as monotherapy or co-administered with atorvastatin,
all 2 news articles >>
  
    



Covidien says FDA extends review of opiod pain drug   - 14 Hours ago
-0400 (Reuters Health) * FDA sets Feb. 22, 2010, as new action date * Says FDA needs more time to review additional data BANGALORE (Reuters) - Covidien Plc said U.S. health regulators extended the review
all 2 news articles >>
  
    




Roche's Actemra successful in arthritis study   - 14 Hours ago
-0400 (Reuters Health) * Improves symptoms of sJIA after 12 weeks of therapy * Meets primary endpoint in phase III study * EMA rules against Avastin use for aggressive brain cancer * Stock up 0.1 pct
all 7 news articles >>
  
    



FDA Approves Bristol-Myers' Abilify To Treat Irritabilty In Pediatric Patients With   - 14 Hours ago
(RTTNews) - Biopharmaceutical company Bristol-Myers Squibb Co. (BMY: News ) and Otsuka Pharmaceutical Co., Ltd. said Friday that U.S. Food and Drug Administration or FDA has approved the supplemental
  
    



Pfizer to pay $6.3 mln to patient in Prempro lawsuit   - 15 Hours ago
LOS ANGELES, Nov 20 (Reuters) - A Philadelphia jury on Friday ordered pharmaceutical giant Pfizer (PFE.N: Quote, Profile, Research) to pay $6.3 million in compensatory damages to an Illinois breast cancer
all 1 news articles >>
  
    



Istanbul Opens Worldâ??s Largest Earthquake-Safe Building   - 15 Hours ago
The worldâ??s largest seismically isolated building, the new international terminal at Istanbulâ??s Sabiha Gökçen Airport, is now complete and open for business. Stretching across more than 2 million
all 3 news articles >>
  
    


Ernst & Young - The right transaction Sponsored
No matter what the size of your company, where it is located or the business you are in, transactions can help your company grow, prosper or reinvent itself. The Ernst and Young Transaction professionals can play a critical role at every step of the deal lifecycle.  Learn More



Ligand receives US$ 2 mn milestone payments from Merck for research pact   - 4 Hours ago
Ligand Pharmaceuticals Incorporated has received US$ 2 million in milestone payments from N V Organon, a subsidiary of Merck & Co, Inc, stemming from its research collaboration that is due to expire at
all 9 news articles >>
  
    



Drug firms tired song and dance on reform   - 8 Hours ago
IN MAKING a fool of President Obama, Big Pharma has turned itself into a poison pill of health care reform. In the summer, the drug companies offered $8 billion a year over 10 years in drug cost cuts,
  
    



Flu season, ailing economy aiding Michigan drug maker   - 8 Hours ago
ALLEGAN Record profits. Job openings. Shareholders making money. It's not what you might think in Michigan, home to the country's highest unemployment rate, but a century-old company is in robust health
all 1 news articles >>
  
    


Reach your target audience with AdBlade! Sponsored
- Brand your product
- Create awareness in your product
- Drive traffic

And do it all on a CPC basis of as little as 50 cents.  Try AdBlade and begin reaching your targ.  Learn More



U.S. Court of Appeals Upholds AstraZeneca AWP Settlement   - 4 Hours ago
Objector's arguments dismissed; ruling may speed settlements in other similar cases. BOSTON, Nov. 20 /PRNewswire/ -- The United States Court of Appeals for the First Circuit upheld an earlier District
all 2 news articles >>
  
    



AstraZeneca Submits New Heart Drug Application   - 10 Hours ago
AstraZeneca has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for ticagrelor, a novel new treatment for cardiac events in patients with acute coronary syndrome. This
all 4 news articles >>
  
    



Genentech & Biogen Idec get complete response letter from US FDA for Rituxan to   - 11 Hours ago
Genentech, Inc, a wholly-owned member of the Roche Group and Biogen Idec announced that the US Food and Drug Administration (FDA) issued a complete response on the companies' applications for Rituxan
  
    


American Express takes you places Sponsored
The Preferred Rewards Gold Card takes you places. And shows you’ve arrived. Enjoy Gold Card benefits and access while you earn travel rewards fast. Earn 10,000 Membership Rewards® bonus points redeemable for rewards after your first purchase.  Learn More



PolyMedix Secures $20.7 Million Equity Financing   - 12 Hours ago
(Close-Up Media via COMTEX) -- PYMX | Quote | Chart | News | PowerRating -- PolyMedix Inc., a biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular
all 1 news articles >>
  
    



Big Pharma Mergers: Good News Or Bad?   - 13 Hours ago
Whoever says you can't throw money at problems hasn't spent much time following the Big Pharma sector this year. More than $160 billion worth of buyouts involving top drugmakers has already been inked
  
    



FDA Takes Action Against Dairy Farm and Owner   - 13 Hours ago
Judge Marvin J. Garbis of the United States District Court for the District of Maryland entered a Consent Decree of Permanent Injunction (Decree) against Old Carolina Farm and its owner, Francis Roderick,
all 3 news articles >>
  
    



Glaxo recalls vaccine lot over allergic reactions   - 15 Hours ago
CTV News Video More than 100,000 doses of the H1N1 vaccine were withdrawn on Thursday after a number of people who got the shot suffered a potentially deadly allergic reaction. Manitoba's Chief Medical
all 1 news articles >>
  
    



NUCRYST Announces Special Meeting of Shareholders   - 3 Hours ago
PRINCETON, NJ, Nov. 20 /PRwire-FirstCall/ - NUCRYST Pharmaceuticals Corp. announced today that a Special Meeting of Shareholders will be held on Monday, December 21, 2009. The purpose of the Meeting is
all 8 news articles >>
  
    



Novartis Holds Medical Lecture on a New Drug for Osteoporosis   - 75 Minutes ago
In light of the Jordanian medical conference on osteoporosis a medical lecture was made with cooperation of Novartis to introduce the new published studies related to the annual injection used for the
  
    



Par Pharmaceutical Receives Final Approval to Market Generic Ultram ER   - 75 Minutes ago
Par to Begin Shipping Tramadol ER Immediately WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it has received final approval
  
    



Aurobindo Pharma sees $2 bn sales in next 3 years   - 2 Hours ago
Aurobindo Pharma has inaugurated a Rs 150 crore drug manufacturing plant at its pharma SEZ in Hyderabad. It expects revenues to hit USD 2 billion by 2013.
  
    



Chinese Fosun Pharma rises on acquisition deal   - 3 Hours ago
BEIJING, Nov. 19 (Xinhua) -- Shanghai Fosun Pharmaceuticals (Group) Co., or Fosun Pharma, rises slightly Thursday morning at the Shanghai Stock Exchange after it announced to have bought stake in the
all 1 news articles >>
  
    



Dendreon Receives FDA Acknowledgement of Complete Response   - 3 Hours ago
-- SEATTLE, Nov. 20 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended
all 5 news articles >>
  
    



Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R)   - 3 Hours ago
First in the Class of Sustained Follicle Stimulants Would Reduce the Number of Treatment Injections for Patients WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc. today announced
all 8 news articles >>
  
    



Archimedes Pharma wins the Scrip Award for SME Pharma Company of the Year   - 8 Hours ago
Archimedes Pharma Limited (Archimedes), the pan-European specialty pharmaceutical company, won the Scrip Award SME Pharma Company of the Year at Wednesdays ceremony at the Grosvenor House, Park Lane,
  
    



Johnson & Johnson cutting 7,000 jobs   - 8 Hours ago
Consumer products giant Johnson & Johnson will lay off six to seven percent of its work force in a cost-cutting move designed to eliminate layers of management, the company said. Globally, 7,000 workers
  
    
*Votes may take up to 30 minutes to influence article rank order
Featured Members
Thomas McNeilly Thomas McNeilly
VP
Pharma Industry
Terry Tormey Terry Tormey
President
Pharma Industry
Joan Bradley Joan Bradley
President
Pharma Industry
Larry Vaughn Larry Vaughn
Sr. Partner
Pharma Industry

  Add your Profile
  View more profiles

   




 
 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.